Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts

Transplantation

Volumn 59, Issue 7, 1995, Pages 1028-1032

  Benham, Adam M ^a   Sawyer, G J ^a   Fabre, John W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOIMMUNITY; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY FORMATION; ANTIGENS; GRAFT REJECTION; ISOANTIGENS; KIDNEY TRANSPLANTATION; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RATS, INBRED LEW; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0028950649     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199504150-00019     Document Type: Article

References (14)

1. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class 1 major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
2. Dalchau R, Fangmann J, Fabre JW. Allorecognition of isolated denatured chains of class I and class II MHC molecules. Evidence for an important role for indirect allorecognition in transplantation. Eur J Immunol 1992; 22: 669.
3. Auchincloss H, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
4. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305.
5. Fangmann J, Dalchau R, Sawyer GJ, Priestley CA, Fabre JW. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur J Immunol 1992; 22: 1525.
6. Liu Z, Yu-Kai S, Yu-Ping X, et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177: 1643.
7. Lechler RI, Batchelor JR. Restoration of immunogenicity to pas senger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
8. Rada C, Lorenzi R, Powis SJ, Bogaerde J, Parham P, Howard JC. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci USA 1990; 87: 2167.
9. Fabre JW, Lim SH, Morris PJ. Renal transplantation in the rat. Aust N Z J Surg 1971; 41: 69.
10. Dalchau R, Fabre JW. Identification and unusual distribution of the canine and human homologues of Thy-1 (θ). J Exp Med 1979; 149: 576.
11. Hart DNJ, Fabre JW. Localization of MHC antigens in longsurviving rat renal allografts: probable implication of the passenger leukocyte in graft adaptation. Transplant Proc 1981; 13: 95.
12. Hart DNJ, Winearls CG, Fabre JW. Graft adaptation: studies on possible mechanisms in long-surviving rat renal allografts. Transplantation 1980; 30: 73.
13. Fabre JW, Morris PJ. The mechanism of specific immunosuppression of renal allograft rejection by donor strain blood. Transplantation 1972; 14: 634.
14. Jeannet M, Pinn VW, Flox MH, Winn HJ, Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111.